Oramed Pharmaceuticals
ORMP
ORMP
50 hedge funds and large institutions have $8.15M invested in Oramed Pharmaceuticals in 2023 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 10 increasing their positions, 14 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
29% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 14
43% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 23
Holders
50
Holding in Top 10
–
Calls
$499K
Puts
$49K
Top Buyers
| 1 | +$589K | |
| 2 | +$262K | |
| 3 | +$132K | |
| 4 |
Squarepoint
New York
|
+$122K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$113K |
Top Sellers
| 1 | -$1.81M | |
| 2 | -$1.6M | |
| 3 | -$910K | |
| 4 |
Morgan Stanley
New York
|
-$860K |
| 5 |
JPMorgan Chase & Co
New York
|
-$431K |